(Q68128629)
Statements
Prolonged continuous intravenous infusion interleukin-2 and lymphokine-activated killer-cell therapy for metastatic renal cell carcinoma (English)
J. A. Thompson
K. L. Shulman
M. C. Benyunes
C. G. Lindgren
C. Collins
P. H. Lange
W. H. Bush
L. A. Benz
1 June 1992